For the past 7 years, pharmaceuticals that work as glucagon-like peptide 1 (GLP-1) receptor agonists have dominated the weight-loss and diabetes markets. These drugs, currently so ... Medical Xpress on MSN: GLP-1 in joint fluid may let weight-loss drugs target arthritis directly Yahoo Finance: Hims & Hers Health (HIMS) Is Up 8.3% After Expanding Novo Nordisk GLP-1 Partnership And Launching New Weight-Loss Membership - Has The Bull Case Changed?

Context Explanation

Hims & Hers Health (HIMS) Is Up 8.3% After Expanding Novo Nordisk GLP-1 Partnership And Launching New Weight-Loss Membership - Has The Bull Case Changed? Even as demand for blockbuster GLP-1 weight-loss drugs explodes, Jefferson Health’s own employees are mostly watching from the sidelines. The system’s chief executive says Jefferson would like to ... If you watched the Super Bowl in 2026, you likely saw Serena Williams share her weight loss journey on GLP-1 medications in a commercial.

Insight Material

Like millions of others around the country, if you’ve ever ... Morningstar: THE WEIGHT LOSS RESET: NEW SURVEY FINDS AMERICANS SHIFTING FROM "BEACH BODY" GOALS TO METABOLIC HEALTH, RESHAPING SNACKS, AT-HOME MEALS, AND GLP-1 ... THE WEIGHT LOSS RESET: NEW SURVEY FINDS AMERICANS SHIFTING FROM "BEACH BODY" GOALS TO METABOLIC HEALTH, RESHAPING SNACKS, AT-HOME MEALS, AND GLP-1 ... Insider Monkey on MSN: Flowers Foods (FLO) is under pressure from GLP-1 weight-loss treatments and softer consumer sentiment Flowers Foods (FLO) is under pressure from GLP-1 weight-loss treatments and softer consumer sentiment Eli Lilly and Co (NYSE:LLY) is entering the US market slightly ahead of schedule with its oral GLP-1 weight-loss therapy Foundayo, a move Bank of America says could expand the obesity market without ...